In an attempt to understand the mechanism by which MAG-EPA mediates its antitumor effects in colorectal cancer cells, we determined whether this monoglyceride form of omega-3 modulates VEGFR and EGFR signaling pathways in tumor homogenates derived from control (untreated) and MAG-EPA-treated mice. This evidence concerns the gene MAG and neoplasm.